Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer. Zhou Y, D'Andrea VD, Shanmugam SP, Stelter I, et al. Eur Urol 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Zhou Y, D'Andrea VD, Shanmugam SP, Stelter I, et al. Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer. Eur Urol 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.
PMID: 38523005